Correlation Between HUTCHMED DRC and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on HUTCHMED DRC and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Arrowhead Pharmaceuticals.

Diversification Opportunities for HUTCHMED DRC and Arrowhead Pharmaceuticals

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between HUTCHMED and Arrowhead is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between HUTCHMED DRC and Arrowhead Pharmaceuticals

Considering the 90-day investment horizon HUTCHMED DRC is expected to under-perform the Arrowhead Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, HUTCHMED DRC is 1.12 times less risky than Arrowhead Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Arrowhead Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  2,529  in Arrowhead Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  74.00  from holding Arrowhead Pharmaceuticals or generate 2.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HUTCHMED DRC  vs.  Arrowhead Pharmaceuticals

 Performance 
       Timeline  
HUTCHMED DRC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HUTCHMED DRC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

HUTCHMED DRC and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HUTCHMED DRC and Arrowhead Pharmaceuticals

The main advantage of trading using opposite HUTCHMED DRC and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind HUTCHMED DRC and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine